Advertisement

Ads Placeholder
Loading...

Guerbet SA

GBT.PAEURONEXT
Healthcare
Medical - Devices
9.08
-0.22(-2.37%)
U.S. Market opens in 7h 36m

Guerbet SA Fundamental Analysis

Guerbet SA (GBT.PA) shows moderate financial fundamentals with a PE ratio of -1.06, profit margin of -13.78%, and ROE of -33.69%. The company generates $0.8B in annual revenue with moderate year-over-year growth of 5.71%.

Key Strengths

Cash Position100.65%
PEG Ratio0.00
Current Ratio2.49

Areas of Concern

ROE-33.69%
Operating Margin0.17%
We analyze GBT.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -21.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-21.0/100

We analyze GBT.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

GBT.PA struggles to generate sufficient returns from assets.

ROA > 10%
-11.65%

Valuation Score

Excellent

GBT.PA trades at attractive valuation levels.

PE < 25
-1.06
PEG Ratio < 2
0.00

Growth Score

Moderate

GBT.PA shows steady but slowing expansion.

Revenue Growth > 5%
5.71%
EPS Growth > 10%
-32.63%

Financial Health Score

Moderate

GBT.PA shows balanced financial health with some risks.

Debt/Equity < 1
1.64
Current Ratio > 1
2.49

Profitability Score

Weak

GBT.PA struggles to sustain strong margins.

ROE > 15%
-3368.98%
Net Margin ≥ 15%
-13.78%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is GBT.PA Expensive or Cheap?

P/E Ratio

GBT.PA trades at -1.06 times earnings. This suggests potential undervaluation.

-1.06

PEG Ratio

When adjusting for growth, GBT.PA's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Guerbet SA at 0.43 times its book value. This may indicate undervaluation.

0.43

EV/EBITDA

Enterprise value stands at -3.71 times EBITDA. This is generally considered low.

-3.71

How Well Does GBT.PA Make Money?

Net Profit Margin

For every $100 in sales, Guerbet SA keeps $-13.78 as profit after all expenses.

-13.78%

Operating Margin

Core operations generate 0.17 in profit for every $100 in revenue, before interest and taxes.

0.17%

ROE

Management delivers $-33.69 in profit for every $100 of shareholder equity.

-33.69%

ROA

Guerbet SA generates $-11.65 in profit for every $100 in assets, demonstrating efficient asset deployment.

-11.65%

Following the Money - Real Cash Generation

Operating Cash Flow

Guerbet SA generates limited operating cash flow of $61.11M, signaling weaker underlying cash strength.

$61.11M

Free Cash Flow

Guerbet SA produces free cash flow of $31.33M, offering steady but limited capital for shareholder returns and expansion.

$31.33M

FCF Per Share

Each share generates $2.49 in free cash annually.

$2.49

FCF Yield

GBT.PA converts 27.46% of its market value into free cash.

27.46%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.001

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.43

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.15

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.64

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.49

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.34

vs 25 benchmark

ROA

Return on assets percentage

-0.12

vs 25 benchmark

ROCE

Return on capital employed

0.002

vs 25 benchmark

How GBT.PA Stacks Against Its Sector Peers

MetricGBT.PA ValueSector AveragePerformance
P/E Ratio-1.0628.54 Better (Cheaper)
ROE-33.69%738.00% Weak
Net Margin-13.78%-43982.00% (disorted) Weak
Debt/Equity1.640.34 Weak (High Leverage)
Current Ratio2.492806.01 Strong Liquidity
ROA-11.65%-14624.00% (disorted) Weak

GBT.PA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Guerbet SA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

2.83%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

-56.97%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-51.25%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ